This is the Forward’s coverage of Jewish culture where you’ll learn about the latest (and sometimes earliest) in Jewish art, music (including of course Bob Dylan and Leonard Cohen), film, theater, books as well as the secret Jewish history of…
Culture
-
Improve FDA’s Rare Disease Review Process
The Jewish community has long been a leader in supporting medical research and education efforts, especially with regard to those diseases that disproportionately afflict people of Ashkenazi Jewish descent. Creating coalitions with other patient advocates in the rare disease community would give American Jews an opportunity to advance efforts to fight diseases that disproportionately affect…
-
Enlisting Rabbis in the Push for Screening
“My wife and I were married by two rabbis, one Conservative and the other Reform, and neither of them gave us any information about Jewish genetic diseases.” So begins the story of Lawrence Sernovitz, himself now an associate rabbi at the Old York Road Temple-Beth Am in Abington, Pa. A little more than a year…
-
Test, and Then Test Again, Experts Advise
With additional mutations for genetic diseases continuing to be discovered among Ashkenazi Jews, genetic screening advocates are urging people to get tested for newly identified diseases, even if they have already been tested for other diseases. Some people may assume that since our genetic make-up is fixed, a DNA test is something that needs to…
The Latest
-
Accessibility vs. Expertise: Direct-to-Consumer Testing Sparks Debate
Drugstores stock tests that gauge blood sugar levels, predict ovulation, ascertain pregnancy and determine whether illegal drugs are in the bloodstream. And back in May, the Walgreens pharmacy chain announced that it would offer testing kits of another kind: ones intended to detect genetic diseases. Within days of Walgreens’ announcement, however, the retailer tabled its…
-
$1.5 Million for Atlanta Screening
A two-year pilot program that promotes genetic disease awareness and offers carrier screening will be introduced in Atlanta as a result of a $1.5 million grant from the Marcus Foundation, the philanthropy of Home Depot co-founder Bernard Marcus. The Victor Center for the Prevention of Jewish Genetic Diseases will manage the project, which will provide…
-
Therapy Shows Promise in Trials for Hereditary Cancer Patients
An emerging therapy that attacks cancer cells continues to show promise, most recently in two international studies on women who have breast and ovarian cancer and are carriers of cancer-causing mutations particularly prevalent among Ashkenazi Jews. Two trials tested the experimental capsule olaparib on women whose breast or ovarian cancer had spread to other organs,…
-
Rare Connector: Bringing Bloom’s Sufferers Together
For a long time, Sheryl Grossman felt like she was alone in the world. Growing up in Flossmoor, Ill., she didn’t understand why she was so small, and why she had to see so many doctors. At the age of 14, her parents told her that she had Bloom’s syndrome, a rare autosomal recessive genetic…
-
Lawsuit Filed Over Familial Dysautonomia Genetic Patent
A lawsuit now working its way through federal court is adding an interesting twist to the heated debate over genetic patenting. Two scientists from Fordham University are suing Massachusetts General Hospital over a patent on the gene that causes the rare Ashkenazi recessive genetic disorder familial dysautonomia. The two sides are each aligned with groups…
-
Rabbis and Halacha Grapple With Advances in DNA Technology
Advances in genetic analysis and its medical applications are bringing unprecedented, if uneven, change to the world of Jewish law. Most often, the matter of genetics is considered in the context of issues on either end of life’s spectrum: those that relate to fertility and to the identification of post-mortem human remains. “DNA analysis is…
-
Court Ruling Could Affect Genetic Patenting
A federal court ruling striking down patents on two cancer-causing genes has the potential to shake up the world of genetic patenting. Last year, the American Civil Liberties Union, together with 18 individual plaintiffs, brought a suit against Myriad Genetics, which holds the licenses to the patents on the BRCA1 and BRCA2 genes, which can…
-
A Tough Year for Gaucher Sufferers
It has been a year filled with anxiety, fear and disappointment for sufferers from Gaucher disease, who are continuing to deal with the fallout from last year’s shutdown of a pharmaceutical plant. In June 2009, Genzyme, the manufacturer of Cerezyme, then the only approved treatment for type 1 Gaucher disease, was forced to shut down…
Explore
Most Popular
- 1
Sports First Puka Nacua, now Mookie Betts: Why do sports stars keep getting antisemitic around a Jewish streamer?
- 2
Fast Forward After MIT professor’s killing, Jewish influencers spread unverified antisemitism claim
- 3
News Christians are displaying menorahs in their windows post-Bondi Beach attack. Why some Jews object
- 4
Politics This politician refused to say ‘Happy Hanukkah,’ then blamed ‘political correctness’ for the backlash
In Case You Missed It
-
Fast Forward Just before Hanukkah attack, Jewish mayor of Bondi Beach region had been praised for fighting antisemitism
-
Fast Forward Vance says ‘religious liberty is a Christian concept.’ Where does that leave Jews?
-
Culture 26 conceivably believable pop culture predictions for 2026
-
Culture A new organization aims to combat antisemitism and spread Jewish joy in New York’s theater industry
-
Shop the Forward Store
100% of profits support our journalism
